Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1
Article in Molecular Cancer Therapeutics (August 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
A combination of BR101801 and venetoclax enhances antitumor effect in DLBCL cells via c-Myc/Bcl-2/Mcl-1 triple targeting.
Article in American Journal of Cancer Research (February 2023)
Inhibition of SUMOylation enhances DNA hypomethylating drug efficacy to reduce outgrowth of hematopoietic malignancies
Article in Leukemia (February 2023)